Autres langues Revvity, Inc.

Actions

RVTY

US7140461093

Equipement et technologie médicale avancés

Marché Fermé - NYSE 22:00:02 22/09/2026			Varia. 5j.	Varia. 1 janv.
143,31 ^USD	-0,20%		+2,23%	+48,12%

21/09	Revvity, Inc. : Goldman Sachs maintient son opinion neutre	ZM
18/09	Le S&P 500 enregistre un léger repli hebdomadaire, pesé par les services publics	MT

Autres langues

21/09	Analystenempfehlungen: VAT, Porsche, Adidas, CoreWeave, eBay, Meta Platforms…
21/09	Analyst recommendations: Flutter, Constellation Brands, CoreWeave, eBay, Meta Platforms…
18/09	S&P 500 Posts Slight Weekly Decline as Utilities Weigh
09/09	Revvity, Inc. entered into a definitive agreement to acquire Human Cell Design SAS.
09/09	Revvity to Acquire Human Cell Design
09/09	Revvity to Acquire Human Cell Design to Advance Human-Relevant Cell Models for Metabolic Disease Drug Discovery
04/09	Analystenempfehlungen: Volkswagen, Daimler Truck, OMV, Microsoft, Lululemon, Zscaler…
04/09	Analyst recommendations: Microsoft, DocuSign, Intuit, Lululemon Athletica, Zscaler…
01/09	Revvity Faces Growth Challenges Amid Rising Competition, RBC Says
11/08	Revvity : Quarterly Report for Quarter Ending July 5, 2026 (Form 10-Q)
11/08	Tranche Update on Revvity, Inc.'s Equity Buyback Plan announced on October 27, 2025.
11/08	Revvity to Present at Upcoming Investor Conferences
10/08	Revvity Launches Superflex Prenatal Screening System
05/08	Analyst recommendations: Palantir Technologies, McDonald's, Booking Holdings, Arista Networks, Amgen...
04/08	Revvity, Inc. Provides Earnings Guidance for the Full Year 2026
04/08	Revvity, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 05, 2026
04/08	Revvity Fiscal Q2 Adjusted Earnings, Revenue Rise; Fiscal 2026 Outlook Raised
04/08	Revvity raises annual profit, revenue forecasts on strong diagnostics demand
04/08	(RVTY) Revvity Expects Full Year 2026 Revenue Range $2.83B-$2.86B, vs. FactSet Est of $2.83B
04/08	(RVTY) Revvity Expects 2026 Adjusted EPS Range $5.30-$5.40, vs. FactSet Est of $5.24
04/08	Earnings Flash (RVTY) Revvity, Inc. Reports Q2 Revenue $729.7M, vs. FactSet Est of $703.0M
04/08	Earnings Flash (RVTY) Revvity, Inc. Posts Q2 Adjusted EPS $1.41 per Share, vs. FactSet Est of $1.21
04/08	Revvity: Q2 Earnings Snapshot
04/08	Revvity Announces Financial Results for the Second Quarter of 2026
31/07	Revvity Board Declares Quarterly Dividend, Payable on November 13, 2026